Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells

ABSTRACT: Melanoma is an aggressive skin cancer and is highly lethal at advanced stages despite the availability of a variety of established therapeutic options due to the high tumorigenicity and metastatic capacity of melanoma cells. However, there is evidence that changing the lineage of cancer cells leads to a drastic reduction of their tumorigenic potential. Different approaches have been developed to change the phenotype of a cell from one lineage to another, a process called transdifferentiation. In this study, we investigated whether melanoma cells can be transdifferentiated into neurons and how that affects their properties and characteristics. For this reason, we ectopically overexpressed the neuron-specific transcription factors Ascl1, Brn2, Myt1L and NeuroD1 in melanoma cells. We could show that melanoma cells could be transdifferentiated into neuron-like cells that expressed neuronal markers and showed a neuron-like morphology. RNA sequencing and DNA methylation assay were used to further reveal the underlying mechanism. Moreover, the transdifferentiated cells had a significantly reduced tumorigenic and metastatic potential and were more sensitive to radiotherapy compared with their parental counterparts. We conclude that transdifferentiation of cancer cells into terminally differentiated cells could represent a new therapeutic alternative for the treatment of malignant melanoma.

ORGANISM(S): Homo sapiens

PROVIDER: GSE243890 | GEO | 2024/09/22

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells (methylation)

Project description:Melanoma is an aggressive skin cancer and is highly lethal at advanced stages despite the availability of a variety of established therapeutic options due to the high tumorigenicity and metastatic capacity of melanoma cells. However, there is evidence that changing the lineage of cancer cells leads to a drastic reduction of their tumorigenic potential. Different approaches have been developed to change the phenotype of a cell from one lineage to another, a process called transdifferentiation. In this study, we investigated whether melanoma cells can be transdifferentiated into neurons and how that affects their properties and characteristics. For this reason, we ectopically overexpressed the neuron-specific transcription factors Ascl1, Brn2, Myt1L and NeuroD1 in melanoma cells. We could show that melanoma cells could be transdifferentiated into neuron-like cells that expressed neuronal markers and showed a neuron-like morphology. RNA sequencing and DNA methylation assay were used to further reveal the underlying mechanism. Moreover, the transdifferentiated cells had a significantly reduced tumorigenic and metastatic potential and were more sensitive to radiotherapy compared with their parental counterparts. We conclude that transdifferentiation of cancer cells into terminally differentiated cells could represent a new therapeutic alternative for the treatment of malignant melanoma.

2024-09-22 | GSE244106 | GEO

Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells

Project description:Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells

| PRJNA1020415 | ENA

Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells (methylation)

Project description:Direct transdifferentiation of tumorigenic melanoma cells to non-tumorigenic neuron-like cells (methylation)

| PRJNA1021235 | ENA

Hierarchical mechanisms for transcription factor-mediated reprogramming of fibroblasts to neurons

Project description:Here we reveal a hierarchical mechanism in the direct conversion of fibroblasts into induced neuronal (iN) cells mediated by the transcription factors Ascl1, Brn2, and Myt1l. Examination of global transcriptional changes and mapping genome-wide transcription factors occupancy at distinct time points during the transdifferentiation process

2013-04-10 | E-GEOD-43916 | biostudies-arrayexpress

KMT2B is selectively required for neuronal transdifferentiation [RNAseq]

Project description:Transdifferentiation of fibroblasts into induced Neuronal cells (iNs) by neuronal-specific transcription factors Brn2, Myt1l and Ascl1 is a paradigmatic example of inter-lineage conversion across epigenetically distant cells. Despite tremendous progress on the transcriptional hierarchy underlying transdifferentiation, the enablers of the concomitant epigenome resetting remain to be elucidated. Here we investigated the role of KMT2A and KMT2B, two histone H3 lysine 4 methylases with cardinal roles in development, through individual and combined inactivation. We found that Kmt2b, whose human homologue’s mutations cause dystonia, is selectively required for iN conversion through the suppression of the alternative myocyte program and the induction of neuronal maturation genes.

2018-09-26 | GSE120440 | GEO

KMT2B is selectively required for neuronal transdifferentiation [ChIP-seq]

2018-09-29 | GSE120635 | GEO

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.

Project description:Melanoma tumors are highly heterogeneous, comprising of different cell types that vary in their potential for growth and invasion. Heterogeneous expression of the Microphthalmia-associated Transcription Factor (MITF) and the POU domain transcription factor BRN2 (POU3F2) has been found in malignant melanoma. Changing expression of these transcription factors as the disease progresses has been linked to the metastatic mechanism of phenotype switching. We therefore investigated the effects of MITF and BRN2 expression in melanoma growth and metastasis. Depletion of MITF resulted in a cell population that had a slowed cell cycle progression, was less invasive in vitro and had hindered tumor and metastasis forming ability in mouse xenograft studies. BRN2 depletion left a cell population with intact proliferation and invasion in vitro; however metastatic growth was significantly reduced in the mouse xenograft model. These results suggest that the proliferative population within melanoma tumors express MITF, and both MITF and BRN2 are important for metastatic growth in vivo. This finding highlights the importance of BRN2 and MITF expression in development of melanoma metastasis.

2017-08-16 | GSE101434 | GEO

ANDROGEN DRIVES MELANOMA INVASIVENESS AND METASTATIC SPREAD BY INDUCING TUMORIGENIC FUCOSYLATION: Phosphoproteomics

Project description:Melanoma incidence and mortality rates are historically higher for men than women. Although emerging studies have highlighted tumorigenic roles for the male sex hormone androgen and its receptor (AR) in melanoma, cellular and molecular mechanisms underlying these sex-associated discrepancies are poorly defined. Here, we delineate a previously undisclosed mechanism by which androgen-activated AR transcriptionally upregulates fucosyltransferase 4 (FUT4) expression, which drives melanoma invasiveness by interfering with adherens junctions (AJs). Global phosphoproteomic and fucoproteomic profiling, coupled with in vitro and in vivo functional validation, further reveals that AR-induced FUT4 fucosylates L1 cell adhesion molecule (L1CAM), which is required for FUT4-increased metastatic capacity. Tumor microarray and gene expression analyses demonstrate that AR-FUT4-L1CAM-AJs signaling correlates with pathological staging in melanoma patients. By delineating key androgen-triggered signaling that enhances metastatic aggressiveness, our findings help to explain sex-associated clinical outcome disparities and highlight AR/FUT4 and its effectors as potential prognostic biomarkers and therapeutic targets in melanoma.

2024-01-15 | PXD047335 | Pride

ANDROGEN DRIVES MELANOMA INVASIVENESS AND METASTATIC SPREAD BY INDUCING TUMORIGENIC FUCOSYLATION: Fucoproteomics

2024-01-15 | PXD047337 | Pride

BRN2 expression increases anoikis resistance in melanoma.

Project description:Melanoma tumors are highly heterogeneous, comprising of many cell populations that vary in their potential for growth and invasion. Differential transcription factor expression contributes to these phenotypic traits. BRN2, a member of the POU domain family of transcription factors is thought to play important roles in melanoma invasion and metastasis. However, how BRN2 functions during the metastatic process of melanoma remains largely unknown. We therefore investigated the effects of BRN2 expression in melanoma cells with no or low constitutive expression using a doxycycline-inducible system. Induction of BRN2 expression led to reduced proliferation and partial resistance to an inhibitor of mutated BRAF. Whole genome profiling analysis revealed novel targets and signaling pathway changes related to prevention of cell death induced by detachment from the extracellular matrix, known as anoikis resistance. Further investigation confirmed increased survival of BRN2 expressing cell lines in non-adherent conditions. Functionally, expression of BRN2 promoted induction of c-MET levels as well as increased phosphorylation of STAT3. Treatment with crizotinib, a c-MET inhibitor, decreased cellular viability of BRN2 expressing cells under non-adherent conditions to death by anoikis. These results highlight the importance of a largely overlooked transcription factor in the progression and metastasis of melanoma, and may suggest a strategy to target BRN2 expressing cells resistant to therapy and cell death by anoikis.

2020-02-25 | GSE145806 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data